Раздел 5.4.1
1. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. S. Bielack, G. Delling, G. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer-Kuntschik, M. Werner, W. Winkelmann, A. Zoubek, K. Winkler. Prognostic J. Clin. Oncol. 2002;20:776–790.
2. Long-term outcomes and complications in pediatric Ewing sarcoma. S. Hamilton, R. Carlson, H. Hasan, et al. Am J Clin Oncol. 2017;40:423–8.
3. Prognostic factors for survival among patients with primary bone sarcomas of small bones. Zhan Wang,* Shu Li,* Yong Li,1 Nong Lin,1 Xin Huang,1 Meng Liu,1 Weibo Pan,1 Xiaobo Yan,1 Lingling Sun,1 Hengyuan Li,1 Binghao Li,1 Hao Qu,1 Yan Wu,1 Peng Lin,1 and Zhaoming Ye.Cancer Manag Res. 2018; 10: 1191–1199.
4. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma. Guijun Xu MD, Haixiao Wu PhD, Yao Xu MD, Yanting Zhang MD, Feng Lin MD, Vladimir P Baklaushev PhD, Vladimir P Chekhonin PhD, Karl Peltzer PhD, Xin Wang PhD, Min Mao PhD, Guowen Wang PhD, Ping Cui PhD, Chao Zhang PhD. Orthopaedic Surgery: Volume13, Issue1 February 2021. Pages 134-144.
5. Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice. Sun Xina and Guo Wei. J Bone Oncol. 2020 Apr; 21.
6. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. P. Casali, S. Bielack, N. Abecassis и др. Annals of Oncology: Official Journal of the European Society for Medical Oncology . 2018; 29 (Suppl 4): iv79–95.
7. Cool P., Grimer R., Rees R. Monitoring of patients with limb sarcoma. European Journal of Surgical Oncology. European Journal of Surgical Oncology European Journal of Surgical Oncology (EJSO) 2005; 31 (9):1020–1024.
8. Саркомы костей. Практические рекомендации RUSSCO. А. Феденко, А. Бохян, В. Горбунова, А. Махсон, В. Тепляков, 2021 (том 11). 17
9. Bone sarcomas : ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
10. 10. PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, S Bonvalot, I Boukovinas, JVMG Bovee, B Brennan, et al. (2018) ANNALS OF ONCOLOGY. 29(suppl. 4). p.79-95